Achieve high transfection efficiencies and viabilities in almost every cell type. Our R&D facility in Cologne, Germany, invented Nucleofection^®, the non-viral transfection technology that is now employed by leading labs worldwide. Combining Nucleofection^® technology and thorough processes, Lonza’s transfection expertise ensures your milestones and research objectives are met.

• Validated stable clones - Meet your deadlines faster
• Transiently transfected cell lines and primary cells - Achieve high transfection efficiency
• Assay ready cells cryopreserved in multi-well plates - Speed up your assay development
• Optimized Nucleofection^® protocols Let us do the optimization for your cell type of interest
• Small-scale protein production - Get your protein of interest quickly and conveniently

Proven Expertise and a Diverse Offering

Achieve high transfection efficiencies and viabilities in almost every cell type. Our R&D facility in Cologne, Germany, invented Nucleofection ^® the non-viral transfection technology that is now employed by leading labs worldwide. Employing Nucleofection ^® technology and thorough processes, Lonza’s transfection expertise ensures your milestones and research objectives are met.